Adjuvant "sandwich" radiation therapy for bladder cancer

Area of Science:

• Oncology
• Radiation Oncology

Background:

• Bladder cancer treatment often involves radiotherapy.
• Adjuvant radiotherapy aims to reduce recurrence after surgery.
• Balancing treatment efficacy with patient morbidity is crucial.

Purpose of the Study:

• To evaluate a novel adjuvant "sandwich" radiotherapy concept for bladder cancer.
• To assess the efficacy and safety of a staged radiotherapy approach based on histopathologic findings.

Main Methods:

• A "sandwich" radiotherapy technique involving low-dose preoperative irradiation (500 rads) followed by tailored high-dose postoperative irradiation (4,500 rads) or palliative treatment.
• Patient stratification into superficial (Stage A, B) and invasive (Stage B, C) or advanced (Stage D) disease groups.
• Minimum one-year follow-up for all eighteen patients.

Main Results:

• 16 out of 18 patients (89%) survived with no evidence of tumor after one year.
• One patient died from distant metastasis, and one from peritonitis.
• The observed failure rate is significantly lower than the expected 50% recurrence rate within the first year.

Conclusions:

• The adjuvant "sandwich" radiotherapy approach demonstrates promising outcomes in bladder cancer management.
• This tailored strategy effectively balances treatment risks and benefits, sparing early-stage patients from excessive therapy.
• Further investigation is warranted to confirm these findings in larger cohorts.